LGND
Ligand Pharmaceuticals Inc - Class B
$222.18
+2.03% (+$4.43)
Volume
153,804
52W High
$247.38
52W Low
$98.89
Market Cap
$2.82B
Next Earnings Report
Last Reported
May 14, 2026 Missed
Actual: $1.63
vs. Consensus: $1.65
Price Chart
EPS History: Consensus vs Actual
Last 11 quartersPrice Movement Around Earnings
Q1 2026
May 14, 2026
1-Day:
-2.63%
5-Day:
-5.11%
Q1 2026
May 13, 2026
1-Day:
-1.01%
5-Day:
-6.02%
Q1 2026
May 7, 2026
1-Day:
+5.27%
5-Day:
+5.55%
Q4 2025
Mar 4, 2026
1-Day:
-1.28%
5-Day:
-0.38%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $59.7M | +39.4% | 143.6% | 33.6% | $44.8M |
| Q3'25 | $115.5M | +122.9% | 78.5% | 47.6% | $117.3M |
| Q2'25 | $47.6M | +14.7% | 93.9% | 17.7% | $4.8M |
| Q1'25 | $45.3M | +46.3% | 89.3% | -79.9% | -$42.5M |
| Q4'24 | $42.8M | +52.4% | 93.4% | -22.5% | -$31.1M |
| Q3'24 | $51.8M | +57.6% | 75.9% | 6.1% | -$7.2M |
| Q2'24 | $41.5M | +57.5% | 136.9% | -46.0% | -$51.9M |
| Q1'24 | $31.0M | -29.6% | 64.3% | 9.7% | $86.1M |
Company Information
Symbol
LGND
Company
Ligand Pharmaceuticals Inc - Class B
Market Cap
$2.82B